← Leaderboards
Gordon H Williams
Harvard University (Medical School)
$31,588,653
Attributed
$31,685,686
Total exposure
33
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$45,217,105 · 34
By mechanism
R01$19,016,737 · 8
P50$14,416,149 · 2
T32$7,449,451 · 1
K30$1,900,000 · 2
M01$1,581,840 · 19
R56$837,928 · 1
Top collaborators
- Amanda Elizabeth Garza1 shared
Others in their field
Top investigators on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Paula Darby Lipman · Westat, Inc.$52,914,492
- Walter N Kernan · Yale University$42,197,025
- Rohit Varma · University Of Southern California$35,266,606
- Susan S Redline · Brigham And Women'S Hospital$35,248,244
- Marlene Rabinovitch · Stanford University$34,807,202
Research focus
HypertensionAldosteroneBlood PressureClinical ResearchGenotypePhenotypeMediatingSodiumResponseSalt IntakeBlood VesselsCellsKidneyGenesGeneticAdrenal GlandsMineralocorticoid ReceptorIntakeHuman SubjectCardiovascular DiseasesProteinsIn VitroSodium ChlorideTissues
Grant awards (96)
Salt Sensitive Hypertension and Striatin$833,979
R01 · FY2022 · HL · contact PI
Salt Sensitive Hypertension and Striatin$833,979
R01 · FY2021 · HL · contact PI
Salt Sensitive Hypertension and Striatin$833,979
R01 · FY2020 · HL · contact PI
Salt Sensitive Hypertension and Striatin$835,768
R01 · FY2019 · HL · contact PI
Striatin, Aldosterone and Hypertension$837,928
R56 · FY2018 · HL · contact PI
Training Program in Hypertension$283,893
T32 · FY2017 · HL · contact PI
Diversity Supplement - Striatin, Aldosterone and Hypertension$194,066
R01 · FY2017 · HL
Striatin, Aldosterone and Hypertension$1,126,080
R01 · FY2016 · HL · contact PI
Training Program in Hypertension$526,909
T32 · FY2016 · HL · contact PI
Striatin, Aldosterone and Hypertension$987,228
R01 · FY2015 · HL · contact PI
Training Program in Hypertension$603,977
T32 · FY2015 · HL · contact PI
Striatin, Aldosterone and Hypertension$126,773
R01 · FY2015 · HL · contact PI
Striatin, Aldosterone and Hypertension$820,493
R01 · FY2014 · HL · contact PI
Training Program in Hypertension$608,031
T32 · FY2014 · HL · contact PI
Striatin, Aldosterone and Hypertension$139,032
R01 · FY2014 · HL · contact PI
Striatin, Aldosterone and Hypertension$100,000
R01 · FY2014 · HL · contact PI
Striatin, Aldosterone and Hypertension$817,621
R01 · FY2013 · HL · contact PI
Training Program in Hypertension$530,508
T32 · FY2013 · HL · contact PI
Genetics of Human Hypertension$711,240
R01 · FY2011 · HL · contact PI
Training Program in Hypertension$326,655
T32 · FY2011 · HL · contact PI
International Aldosterone Conference - Cardiovascular$15,000
R13 · FY2011 · HL · contact PI
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus$892,710
R01 · FY2010 · HL · contact PI
Genetics of Human Hypertension$718,065
R01 · FY2010 · HL · contact PI
Aldosterone, Histone Demethylase and Cardiovascular Disease$621,630
R01 · FY2010 · HL · contact PI
Training Program in Hypertension$553,954
T32 · FY2010 · HL · contact PI
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus$888,853
R01 · FY2009 · HL · contact PI
Genetics of Human Hypertension$715,960
R01 · FY2009 · HL · contact PI
Aldosterone, Histone Demethylase and Cardiovascular Disease$631,481
R01 · FY2009 · HL · contact PI
Training Program in Hypertension$549,587
T32 · FY2009 · HL · contact PI
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus$867,235
R01 · FY2008 · HL · contact PI
Genetics of Human Hypertension$698,101
R01 · FY2008 · HL · contact PI
Training Program in Hypertension$545,232
T32 · FY2008 · HL · contact PI
THE EFFECTS OF MIDODRINE ON ORTHOSTATIC TOLERANCE IN WOMEN$14,682
M01 · FY2008 · RR · contact PI
VASCULAR DYSFUNCTION IN DIABETES: GENES AND HORMONES$456
M01 · FY2008 · RR · contact PI
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus$817,696
R01 · FY2007 · HL · contact PI
Genetics of Human Hypertension$693,509
R01 · FY2007 · HL · contact PI
Training Program in Hypertension$545,232
T32 · FY2007 · HL · contact PI
SCHOLARS IN CLINICAL SCIENCE PROGRAM$300,000
K30 · FY2007 · RR · contact PI
THE EFFECTS OF MIDODRINE ON ORTHOSTATIC TOLERANCE IN WOMEN$98,405
M01 · FY2007 · RR · contact PI
VASCULAR DYSFUNCTION IN DIABETES: GENES AND HORMONES$3,057
M01 · FY2007 · RR · contact PI
Mechanisms of Aldosterone Induced Cardiovascular Damage$459,771
R01 · FY2006 · HL · contact PI
SCHOLARS IN CLINICAL SCIENCE PROGRAM$300,000
K30 · FY2006 · RR · contact PI
THE EFFECTS OF MIDODRINE ON ORTHOSTATIC TOLERANCE IN WOMEN$247,828
M01 · FY2006 · RR · contact PI
EFFECTS OF SIMULATED MICROGRAVITY ON ORTHOSTATIC TOLERANCE$100,560
M01 · FY2006 · RR · contact PI
VASCULAR DISEASE AND HIGH BLOOD PRESSURE: PA 1, INSULIN AND GENES$42,313
M01 · FY2006 · RR · contact PI
VASCULAR DYSFUNCTION IN DIABETES: GENES AND HORMONES$8,243
M01 · FY2006 · RR · contact PI
ASSESSMENT OF CORONARY FLOW RESERVE, DIASTOLIC FUNCTION AND RENAL BLOOD FLOW$4,946
M01 · FY2006 · RR · contact PI
SCOR MOLECULAR GENETICS OF HYPERTENSION$2,616,948
P50 · FY2005 · HL
Mechanisms of Aldosterone Induced Cardiovascular Damage$459,411
R01 · FY2005 · HL
TRAINING PROGRAM IN HYPERTENSION$440,263
T32 · FY2005 · HL
Genetic determinants of RAA system and hypertension$400,088
P50 · FY2005 · HL
SCHOLARS IN CLINICAL SCIENCE PROGRAM$300,000
K30 · FY2005 · RR
VASCULAR DISEASE AND HIGH BLOOD PRESSURE: PA 1, INSULIN AND GENES$195,144
M01 · FY2005 · RR
EFFECTS OF SIMULATED MICROGRAVITY ON ORTHOSTATIC TOLERANCE$145,577
M01 · FY2005 · RR
PARTNERS/ROCHE TYPE 2 DIABETES PROJECT$126,374
M01 · FY2005 · RR
ASSESSMENT OF CORONARY FLOW RESERVE, DIASTOLIC FUNCTION AND RENAL BLOOD FLOW$43,315
M01 · FY2005 · RR
VASCULAR DYSFUNCTION IN DIABETES: GENES AND HORMONES$30,812
M01 · FY2005 · RR
INSULIN/ANGIOTENSIN II VASCULAR INTERACTIONS$23,220
M01 · FY2005 · RR
SCOR MOLECULAR GENETICS OF HYPERTENSION$2,522,404
P50 · FY2004 · HL
Mechanisms of Aldosterone Induced Cardiovascular Damage$448,225
R01 · FY2004 · HL
Training Program in Hypertension$417,539
T32 · FY2004 · HL
SCHOLARS IN CLINICAL SCIENCE PROGRAM$200,000
K30 · FY2004 · HL
Partners/Roche Type 2 Diabetes Project$186,231
M01 · FY2004 · RR
Vascular Disease and High Blood Pressure: PA 1, Insulin and Genes$142,411
M01 · FY2004 · RR
Renal Renin and Angiotensinogen$90,705
M01 · FY2004 · RR
Insulin /Angiotensin II Vascular Interactions$57,403
M01 · FY2004 · RR
Vascular Dysfunction in Diabetes: Genes and Hormones$15,337
M01 · FY2004 · RR
Coronary Flow Reserve, Diastolic Function, Renal Blood F$4,821
M01 · FY2004 · RR
SCOR MOLECULAR GENETICS OF HYPERTENSION$2,460,338
P50 · FY2003 · HL
Mechanisms of Aldosterone Induced Cardiovascular Damage$473,345
R01 · FY2003 · HL
TRAINING PROGRAM IN HYPERTENSION$460,660
T32 · FY2003 · HL
SCHOLARS IN CLINICAL SCIENCE PROGRAM$200,000
K30 · FY2003 · HL
SCOR MOLECULAR GENETICS OF HYPERTENSION$2,142,938
P50 · FY2002 · HL
TRAINING PROGRAM IN HYPERTENSION$444,481
T32 · FY2002 · HL
Genetic determinants of RAA system and hypertension$237,978
P50 · FY2002 · HL
SCHOLARS IN CLINICAL SCIENCE PROGRAM$200,000
K30 · FY2002 · HL
VASCULAR DISEASE AND HIGH BLOOD PRESSURE--PA1, INSULIN AND GENES$0
M01 · FY2002 · RR
EFFECTS OF DISRUPTIVE SLEEP ON HORMONAL AND RENAL RESPONSE TO POSTURE$0
M01 · FY2002 · RR
GENETICS OF HUMAN HYPERTENSION$0
M01 · FY2002 · RR
SCOR MOLECULAR GENETICS OF HYPERTENSION$2,176,923
P50 · FY2001 · HL
VASCULAR DISEASE IN HBP--ANGII, PAI1, INSULIN AND GENES$489,299
R01 · FY2001 · HL
TRAINING PROGRAM IN HYPERTENSION$407,165
T32 · FY2001 · HL
SCHOLARS IN CLINICAL SCIENCE PROGRAM$200,000
K30 · FY2001 · HL
EFFECTS OF DISRUPTIVE SLEEP ON HORMONAL AND RENAL RESPONSE TO POSTURE$0
M01 · FY2001 · RR
Genetic determinants of RAA system and hypertension$0
P50 · FY2001 · HL
VASCULAR DISEASE AND HIGH BLOOD PRESSURE--PA1, INSULIN AND GENES$0
M01 · FY2001 · RR
GENETICS OF HUMAN HYPERTENSION$0
M01 · FY2001 · RR
SCOR MOLECULAR GENETICS OF HYPERTENSION$1,611,868
P50 · FY2000 · HL
VASCULAR DISEASE IN HBP--ANGII, PAI1, INSULIN AND GENES$477,086
R01 · FY2000 · HL
MECHANISMS UNDERLYING CARDIOVASCULAR RISKS IN DIABETES$304,122
R01 · FY2000 · HL
GENETICS OF HUMAN HYPERTENSION$246,664
P50 · FY2000 · HL
TRAINING PROGRAM IN HYPERTENSION$205,365
T32 · FY2000 · HL
SCHOLARS IN CLINICAL SCIENCE PROGRAM$200,000
K30 · FY2000 · HL
VASCULAR DISEASE AND HIGH BLOOD PRESSURE--PA1, INSULIN AND GENES$0
M01 · FY2000 · RR
EFFECTS OF DISRUPTIVE SLEEP ON HORMONAL AND RENAL RESPONSE TO POSTURE$0
M01 · FY2000 · RR
GENETICS OF HUMAN HYPERTENSION$0
M01 · FY2000 · RR